Axsome Therapeutics (AXSM) Selling, General & Administrative (2015 - 2026)
Axsome Therapeutics' Selling, General & Administrative was $208.14 million in Q2 2026, up 59.8% from $130.28 million a year earlier and up 12.5% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Selling, General & Administrative (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Axsome Therapeutics' Selling, General & Administrative was $712.67 million through Jun 30, 2026, up 55.0% year-over-year; for FY2025, it came in at $570.6 million, up 38.7% from FY2024.
- Selling, General & Administrative has now increased for 11 consecutive years, with a five-year compound annual growth rate of 81.6% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $411.36 million in FY2024 (+27.3%), $323.12 million in FY2023 (+102.9%), $159.25 million in FY2022 (+139.0%) and $66.65 million in FY2021 (+130.6%).
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q1 2015.
- Compared with a year earlier, Selling, General & Administrative has increased for 42 straight quarters, with growth averaging 39.1% over the last eight quarters.
- Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 14.9% (Q3 2024) to 226.7% (Q4 2022).
- Per Business Quant data, AXSM's Selling, General & Administrative in the three quarters before Q2 2026 was $185 million (Q1 2026), $169.3 million (Q4 2025) and $150.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Axsome Therapeutics | 9.37 Bn | 8.10 Bn | 204.81 Mn | 208.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 208.14 Mn |
| Mar 31, 2026 | 185.00 Mn |
| Dec 31, 2025 | 169.30 Mn |
| Sep 30, 2025 | 150.24 Mn |
| Jun 30, 2025 | 130.28 Mn |
| Mar 31, 2025 | 120.79 Mn |
| Dec 31, 2024 | 113.27 Mn |
| Sep 30, 2024 | 95.56 Mn |
| Jun 30, 2024 | 103.55 Mn |
| Mar 31, 2024 | 98.97 Mn |
| Dec 31, 2023 | 86.81 Mn |
| Sep 30, 2023 | 83.19 Mn |
| Jun 30, 2023 | 78.94 Mn |
| Mar 31, 2023 | 74.19 Mn |
| Dec 31, 2022 | 61.50 Mn |
| Sep 30, 2022 | 40.89 Mn |
| Jun 30, 2022 | 31.16 Mn |
| Mar 31, 2022 | 25.70 Mn |
| Dec 31, 2021 | 18.83 Mn |
| Sep 30, 2021 | 20.23 Mn |
API Access
Axsome Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();